Vox Sanguinis

Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation sensitivity by liquid<b>-</b>heating
pp. 93-99(7)
Authors: Tsujikawa, M.; Nishigaki, H.; Yoshikawa, M.; Furuki, R.; Takahashi, K.; Adan-Kubo, J.; Shimamura, Y.; Urayama, T.; Hattori, S.; Sakai, K.; Yunoki, M.; Ikuta, K.

Comparison of candidate vCJD <i>in vitro</i> diagnostic assays using identical sample sets
pp. 100-109(10)
Authors: Cooper, J. K.; Ladhani, K.; Minor, P.

Feasibility of a closed-system cell processor (ACP215) for automated preparation of washed platelet concentrates
pp. 110-115(6)
Authors: Oikawa, S.; Sasaki, D.; Kikuchi, M.; Sawamura, Y.; Itoh, T.

Fresh frozen plasma quality: relation to age and gender of blood donors
pp. 116-124(9)
Authors: Madla, W.; Alt, T.; Jungk, H.; Bux, J.

Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma
pp. 125-133(9)
Authors: Norda, R.; Schött, U.; Berséus, O.; Åkerblom, O.; Nilsson, B.; Ekdahl, K. N.; Stegmayr, B. G.; Knutson, et F.

Safety and frequency of whole blood donations from elderly donors
pp. 134-139(6)
Authors: Müller-Steinhardt, M.; Müller-Kuller, T.; Weiß, C.; Menzel, D.; Wiesneth, M.; Seifried, E.; Klüter, H.

The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products
pp. 140-143(4)
Authors: O'Mahony, B.; Turner, A.

Red-blood-cell alloimmunization and number of red-blood-cell transfusions
pp. 144-149(6)
Authors: Zalpuri, S.; Zwaginga, J. J.; le Cessie, S.; Elshuis, J.; Schonewille, H.; van der Bom, J. G.

Iron studies and red cell transfusion in cardiothoracic and orthopaedic surgical patients: a retrospective audit at a tertiary hospital
pp. 150-158(9)
Authors: Grey, D. E.; Smith, V.; Finlayson, J.

Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test
pp. 159-166(8)
Authors: Höchsmann, B.; Leichtle, R.; von Zabern, I.; Kaiser, S.; Flegel, W. A.; Schrezenmeier, H.

Molecular basis of the rare gene complex, <i>DIVa(C)-</i>, which encodes four low-prevalence antigens in the Rh blood group system
pp. 167-170(4)
Authors: Hipsky, C. H.; Hue-Roye, K.; Lomas-Francis, C.; Huang, C.-H.; Reid, M. E.

A standardized immunofluorescence test method with human neutrophil antigen-expressing cell lines to enhance antibody detection
pp. 171-174(4)
Authors: Lopez, G. H.; Dean, M. M.; Yasui, K.; Schuller, R. M.; Hirayama, F.; Fung, Y. L.

ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets
pp. 175-177(3)
Authors: Yazer, M. H.; Raval, J. S.; Triulzi, D. J.; Blumberg, N.

Pathogen inactivation of plasma components
pp. 178-179(2)
Authors: Corash, L.; Stassinopoulos, A.

Response Letter
pp. 180-181(2)
Author: Rock, G.

Widespread distribution of hepatitis E virus in plasma fractionation pools
pp. 182-183(2)
Authors: Baylis, S. A.; Koc, Ö.; Nick, S.; Blümel, J.

Diary of Events
pp. 184-184(1)